Spectral AI Inc. Warrants (MDAIW)
Stock · NASDAQ · Health Care
$0.445as of 10/16/2026
Price chart
Active signals
High Beta100.0%
Resistance level
$0.451625
Industry
Medical/Dental Instruments
About MDAIW
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds cap…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 65
Fundamentals
- 1-day range
- $0.401$0.4901
- Market cap
- $15.91M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 4.73
- Avg. volume
- —
52-week range
$0.355$1.01
Spectral AI Inc. Warrants Competitors
Chosen by industry and closest market cap.
- MDAIWSpectral AI Inc. Warrants$0.445▲ 8.54%Market cap $15.91MP/E —$0.355$1.01
- ADGMAdagio Medical Holdings Inc Common Stock$0.099▼ 3.88%Market cap $16.26MP/E —$0.083$2.02
- OSRHOSR Health Inc. Common Stock$0.226▲ 13.00%Market cap $15.32MP/E 12.44$0.075$0.9078
- NMTCNeuroOne Medical Technologies Corporation Common Stock$0.961▼ 7.60%Market cap $13.36MP/E —$0.9615$6.96
- ICUSeaStar Medical Holding Corporation Common Stock$2.9▼ 5.23%Market cap $12.19MP/E —$2.07$7.35
- AMIXAutonomix Medical Inc. Common Stock$2.85▼ 2.90%Market cap $11.82MP/E —$2.44$32.55
- RVPRetractable Technologies Inc. Common Stock$0.58▼ 1.69%Market cap $20.27MP/E —$0.5844$1.14
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MDAIW Spectral AI Inc. Warrants | $15.91M | — | $0.445 | ▲ 8.54% | $0.355$1.01 |
| ADGM Adagio Medical Holdings Inc Common Stock | $16.26M | — | $0.099 | ▼ 3.88% | $0.083$2.02 |
| OSRH OSR Health Inc. Common Stock | $15.32M | 12.44 | $0.226 | ▲ 13.00% | $0.075$0.9078 |
| NMTC NeuroOne Medical Technologies Corporation Common Stock | $13.36M | — | $0.961 | ▼ 7.60% | $0.9615$6.96 |
| ICU SeaStar Medical Holding Corporation Common Stock | $12.19M | — | $2.9 | ▼ 5.23% | $2.07$7.35 |
| AMIX Autonomix Medical Inc. Common Stock | $11.82M | — | $2.85 | ▼ 2.90% | $2.44$32.55 |
| RVP Retractable Technologies Inc. Common Stock | $20.27M | — | $0.58 | ▼ 1.69% | $0.5844$1.14 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ SystemYahoo · 10/6/2026
- Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and FeetYahoo · 10/1/2026
- Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn WoundsYahoo · 9/24/2026
- Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn ConferenceYahoo · 9/16/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 2.06M
- Total value held
- $1.19M
- Institutional holders
- 20
Top holders this quarter
- Unknown359.9K
- Unknown307.5K
- Unknown285.2K
- Unknown123.6K
- Unknown117.9K
- Unknown100.0K
- Unknown100.0K
- Unknown99.7K
- Unknown83.5K
- Unknown81.5K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Spectral AI to Present AI & Multi‑Spectral Imaging for Burn at ACS
Spectral AI will showcase its AI‑driven multi‑spectral imaging platform at the ACS Clinical Congress in 2026. The talk will explain how the technology can improve burn wound assessment. The event highlights the company’s push to bring AI into clinical practice.
Spectral AI to Present AI & Multi‑Spectral Imaging for Burn at ACS. Spectral AI will showcase its AI‑driven multi‑spectral imaging platform at the ACS Clinical Congress in 2026. The talk will explain how the technology can improve burn wound assessment. The event highlights the company’s push to bring AI into clinical practice.